SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 373 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | -88.9% | 70 | -87.7% | 0.00% | -87.5% |
| Q1 2022 | $45,000 | -11.8% | 570 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $51,000 | -48.5% | 570 | -46.7% | 0.01% | -55.6% |
| Q3 2021 | $99,000 | +19.3% | 1,070 | 0.0% | 0.02% | +20.0% |
| Q2 2021 | $83,000 | +3.8% | 1,070 | 0.0% | 0.02% | -16.7% |
| Q1 2021 | $80,000 | -18.4% | 1,070 | +85.8% | 0.02% | -28.0% |
| Q4 2020 | $98,000 | +60.7% | 576 | +32.1% | 0.02% | +25.0% |
| Q3 2020 | $61,000 | +60.5% | 436 | +84.7% | 0.02% | +33.3% |
| Q2 2020 | $38,000 | +81.0% | 236 | +11.8% | 0.02% | +50.0% |
| Q1 2020 | $21,000 | +50.0% | 211 | +99.1% | 0.01% | +100.0% |
| Q4 2019 | $14,000 | +75.0% | 106 | 0.0% | 0.01% | +25.0% |
| Q3 2019 | $8,000 | -50.0% | 106 | 0.0% | 0.00% | -42.9% |
| Q2 2019 | $16,000 | +1500.0% | 106 | +1666.7% | 0.01% | +600.0% |
| Q1 2019 | $1,000 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |